Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer.
Katya
K
Brede-Hekimian
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors*
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases